How were Amarillo Biosciences' earnings last quarter?

Amarillo Biosciences, Inc. (OTCMKTS:AMAR) announced its quarterly earnings results on Wednesday, November, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.02 million for the quarter.

What other stocks do shareholders of Amarillo Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amarillo Biosciences investors own include Fulcrum Therapeutics (FULC) , Cerecor (CERC) , VIVUS (VVUS) , CymaBay Therapeutics (CBAY) , Spectrum Pharmaceuticals (SPPI) , Sorrento Therapeutics (SRNE) , Vistagen Therapeutics (VTGN) , vTv Therapeutics (VTVT) , Abeona Therapeutics (ABEO) and Bausch Health Companies (BHC) .

How do I buy shares of Amarillo Biosciences?

Shares of AMAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:AMAR

Amarillo Biosciences (AMAR) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free AMAR Stock Alerts

Compare

Today's Range: N/A
50-Day Range: $0.60
▼
$0.60
52-Week Range: N/A

Volume: 6,100 shs
Average Volume: 18,253 shs
Market Capitalization: $25.24 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Amarillo Biosciences alerts:

Ad InvestorPlace

The Next Nvidia?

The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.

Go here now for this breaking story.

About Amarillo Biosciences Stock (OTCMKTS:AMAR)

Amarillo Biosciences, Inc., a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases. The Medical division focuses on medical devices and developing technology to treat metabolism related diseases, such as Type 1 and Type 2 diabetes. The Consumer division provides a range of nutraceutical and food supplement products that utilize a liposomal delivery system. It owns four issued patents related to the low-dose oral delivery of interferon; one patent is for a product promoting oral health; and three patents are associated with treatment of metabolic disorders. The company was incorporated in 1984 and is based in Amarillo, Texas.

Ad InvestorPlace

The Next Nvidia?

Go here now for this breaking story.

AMAR Stock News Headlines

April 3, 2024 | msn.com

Texas Rising Stars award honors two Amarillo lawyers

March 31, 2024 | msn.com

Rising Stars attorneys, Midland wildfire donations among this week's business news

April 18, 2024 | InvestorPlace (Ad)

The Next Nvidia?

January 26, 2024 | yahoo.com

Overnight shooting incidents in Amarillo leave 1 dead, 1 critically injured

December 20, 2023 | investing.com

Gufic Biosciences Ltd (GUFI)

September 6, 2023 | forbes.com

Best Internet Providers In Amarillo, Texas Of 2023

August 29, 2023 | usnews.com

Ojo Amarillo Elementary

May 21, 2023 | cnet.com

Best Internet Providers in Amarillo, Texas

April 18, 2024 | InvestorPlace (Ad)

The Next Nvidia?

March 18, 2023 | cbsnews.com

Federal judge in Amarillo to rule on potential abortion pill ban 'as soon as possible'

March 17, 2023 | cbsnews.com

Abortion pill challenge goes before judge in Amarillo

March 10, 2023 | marketwatch.com

Thrombocytopenia Management Market Size 2023 Research Report by Raw Materials Analysis and Forecast till 2027

February 28, 2023 | msn.com

Potter County Commissioners’ Court rescinds Willow Creek land donation to Homeless Heroes

February 9, 2023 | msn.com

Homeless Heroes holds meeting with Willow Creek residents to address concerns, questions

February 1, 2023 | finance.yahoo.com

Pyramid Biosciences to Present at the B. Riley Securities Third Annual Oncology Conference

January 30, 2023 | marketwatch.com

Interferon Alpha-2a Biosimilar Market 2023 Statistics, Share Price, Growth Prospects, Industry Trends till 2028

January 27, 2023 | news.yahoo.com

Amarillo singer Tony Christie talks about living with dementia

January 23, 2023 | finanznachrichten.de

Ainos, Inc.: Ainos and Tah-An Sign MoU to Explore Manufacture of VELDONA Animal Investigational New Drug

January 23, 2023 | news.yahoo.com

Remains identified as Amarillo man missing since June

January 21, 2023 | news.yahoo.com

Amarillo man sentenced in federal court for transporting woman for prostitution

January 17, 2023 | news.yahoo.com

Amarillo health leader speaks about new COVID variant, heart issues and vaccine effects

January 9, 2023 | thestreet.com

Amarillo Biosciences Inc News

December 31, 2022 | finance.yahoo.com

Journey Biosciences launches NaviDKD™ for people with diabetes to predict long-term kidney complications

September 22, 2022 | newsweek.com

Amarillo Shooting as Officer Gunned Down in 'Pure Chaos' at Tri-State Fair

September 22, 2022 | dallasnews.com

Gunman shoots 3 at Amarillo fair before being shot by deputies

September 21, 2022 | msn.com

U.N. secretary-general warns world leaders: 'We cannot go on like this'

August 16, 2022 | seekingalpha.com

Amarillo Biosciences GAAP EPS of -$0.01, revenue of $636.62M

See More Headlines

Receive AMAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amarillo Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/14/2018
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:AMAR
CUSIP: N/A
CIK: 1014763
Web: www.amarbio.com
Phone: 806-376-1741
Fax: N/A
Employees: 2
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-1,450,000.00
Net Margins: -41,453.98%
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -574.29%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.03
Quick Ratio: 0.07

Sales & Book Value

Annual Sales: $20,000.00
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.03) per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 42,066,000
Free Float: N/A
Market Cap: $25.24 million
Optionable: Not Optionable
Beta: -0.06

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Dr. Stephen T. Chen (Age 71)
Chairman, CEO, Pres, CFO & COO
Comp: $340.98k
Mr. Bernard Cohen (Age 68)
VP of Admin.
Comp: $83.08k
Mr. John Junyong Lee Esq.
Chief Legal Counsel & Sec.

Key Competitors

View All Competitors

AMAR Stock Analysis - Frequently Asked Questions

How were Amarillo Biosciences' earnings last quarter?: Amarillo Biosciences, Inc. (OTCMKTS:AMAR) announced its quarterly earnings results on Wednesday, November, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.02 million for the quarter.
What other stocks do shareholders of Amarillo Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Amarillo Biosciences investors own include Fulcrum Therapeutics (FULC), Cerecor (CERC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Spectrum Pharmaceuticals (SPPI), Sorrento Therapeutics (SRNE), Vistagen Therapeutics (VTGN), vTv Therapeutics (VTVT), Abeona Therapeutics (ABEO) and Bausch Health Companies (BHC).
How do I buy shares of Amarillo Biosciences?: Shares of AMAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AMAR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Amarillo Biosciences (AMAR) Stock Price, News & Analysis

About Amarillo Biosciences Stock (OTCMKTS:AMAR)

AMAR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

AMAR Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info